#Israel #Steel Partners #Yokneam #InMode #INMD

InMode Ltd. Addresses Recent Acquisition Rumors

InMode Ltd. (NASDAQ: INMD), a recognized leader in innovative medical technologies, has recently found itself in the spotlight due to swirling rumors surrounding a potential acquisition. The Israeli-based company is currently navigating through market speculation, particularly concerning a non-binding proposal from Steel Partners Holdings L.P. to acquire a substantial stake—51% of InMode's outstanding shares. In a statement released on February 2, 2026, InMode aimed to clarify its position amid these rumors while emphasizing its dedicated approach to evaluating strategic alternatives.

Overview of Recent Developments

The marketplace has reacted energetically to reports and comments attributed to InMode's leadership, particularly its Chief Executive Officer. In response, InMode has stated that it maintains a general policy of refraining from commenting on market speculation. Nonetheless, the company felt it was necessary to inform its investors about the current situation. The company announced it is actively evaluating various strategic pathways and has even formed a specialized committee comprising independent directors to supervise this comprehensive review process.

This committee is not only steering the assessment but has also engaged independent legal and financial advisors. Their primary focus is to ensure that all matters presented to them—including acquisition proposals from external parties and interactions from within the company—are addressed in alignment with their fiduciary responsibilities and in the best interests of all shareholders.

Future Transactions Uncertain

It’s crucial for investors to approach the news with caution; InMode has clarified that there are no guarantees that this ongoing review will culminate in any kind of transaction or specific strategic outcome. The company has not committed to any timelines or terms concerning potential future decisions, maintaining that it will provide updates solely as required by pertinent laws and regulations. This stance reflects InMode's intention to operate transparently while also protecting shareholder interests.

About InMode's Innovations

As a pioneer in the realm of medical technologies, InMode is dedicated to developing devices that utilize groundbreaking radio frequency (RF) technologies. This commitment enables them to foster new surgical techniques and improve existing treatment modalities. The firm's innovative loops have successfully led to a comprehensive product line covering diverse medical fields, including plastic surgery, dermatology, gynecology, otolaryngology, and ophthalmology.

Through its operations, InMode aims to transform patient care while making minimal invasiveness a key aspect of its technological approach. The company highlights its mission to enhance healthcare standards globally through its state-of-the-art solutions.

For those interested in learning more about InMode and its diverse range of medical technologies, comprehensive details can be found on their official website, www.inmodemd.com.

Conclusion

In summary, while the speculation regarding InMode Ltd.'s possible acquisition has sparked widespread interest, the company remains committed to carrying out a thorough internal review. With strong leadership and a clear commitment to its shareholders, InMode is poised to navigate these rumors responsibly, ensuring that any decisive steps taken are in line with the long-term vision of the company and the best interests of all its stakeholders.